| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/17/2003 | CN1131060C Chinese medicine compound preparation treating fatty liver |
| 12/17/2003 | CN1131059C Life-prolonging tea |
| 12/17/2003 | CN1131052C Preparation method of medicated gargle wine for toothache |
| 12/17/2003 | CN1131045C Aloe capsule prepared from natural aloe and its preparing process |
| 12/17/2003 | CN1131044C External-use medicine for treating cough and diarrhoea in thd four seasons |
| 12/17/2003 | CN1131042C Bee glue preparation for treating stomatocace and its compounding process |
| 12/17/2003 | CN1131038C Application of N-acetyl-D-amineglucose in preparing medicine to help treatment of perianal disease |
| 12/17/2003 | CN1131029C Application of dihydromyricetrin in medicine for preparation of hepatitis |
| 12/16/2003 | US6664279 Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives |
| 12/16/2003 | US6664276 Antiulcer agent |
| 12/16/2003 | US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes |
| 12/16/2003 | US6664264 Thioether substituted imidazoquinolines |
| 12/16/2003 | US6664247 Pyrazole compounds useful as protein kinase inhibitors |
| 12/16/2003 | US6664242 Composition and method comprising CPT-11 and a pyrimidine derivative for the treatment of cancer |
| 12/16/2003 | US6664236 Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents |
| 12/16/2003 | US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 12/16/2003 | US6664069 Use of GABAB receptor agonists in the screening of compounds which are reflux inhibitors |
| 12/16/2003 | US6663878 Anti-inflammatory bioactive glass particulates |
| 12/16/2003 | CA2124578C A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 12/14/2003 | CA2432231A1 Liquid antacid compositions |
| 12/11/2003 | WO2003102025A1 Protein inducing cell death of helicobacter pylori |
| 12/11/2003 | WO2003101993A1 Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents |
| 12/11/2003 | WO2003101987A1 3-substituted quinuclidines and their use |
| 12/11/2003 | WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 12/11/2003 | WO2003101983A1 Tetrahydropyran derivative |
| 12/11/2003 | WO2003101981A1 Novel substituted indoles |
| 12/11/2003 | WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 12/11/2003 | WO2003101970A1 Imidazolium cxcr3 inhibitors |
| 12/11/2003 | WO2003101964A1 Piperidine derivative, process for producing the same, and use |
| 12/11/2003 | WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | WO2003101489A1 Medicinal composition for treatment for digestive tract disease |
| 12/11/2003 | WO2003101478A1 Treatment of hepatitis c in the asian population with subcutaneous interferonbeta |
| 12/11/2003 | WO2003101466A1 Rubrofusarin glycoside-containing composition |
| 12/11/2003 | WO2003101456A1 Use of compounds that stimulate cgmp |
| 12/11/2003 | WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 12/11/2003 | WO2003101454A1 A buffered, liquid nicotine composition for pulmonary administration |
| 12/11/2003 | WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 12/11/2003 | WO2003101424A1 Modified release pharmaceutical formulation |
| 12/11/2003 | WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 12/11/2003 | WO2003101218A1 Process for producing lacturose-containing powder composition, lacturose-containing powder composition obtained by the process and feed additive |
| 12/11/2003 | WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 12/11/2003 | WO2003078588A9 Primitive and proximal hepatic stem cells |
| 12/11/2003 | WO2003059333A3 Stimulation of the immune system with polydextrose |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | WO2003050190A3 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 12/11/2003 | WO2003048117A3 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
| 12/11/2003 | WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 12/11/2003 | WO2003027090A3 Bicyclic heterocycles as rxr ligands |
| 12/11/2003 | WO2003026579A3 Combination therapies for immune mediated diseases |
| 12/11/2003 | WO2003024395A3 Linked biaryl compounds |
| 12/11/2003 | WO2003023042A9 Recombinant mva capable of expressing structural hcv antigens |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2002088114A3 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders |
| 12/11/2003 | WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells |
| 12/11/2003 | WO2002067986A3 Symbiotic regenerative agent |
| 12/11/2003 | WO2002041884A8 Inhibitors of abc drug transporters at the blood-brain barrier |
| 12/11/2003 | US20030229226 Cathepsin cysteine protease inhibitors |
| 12/11/2003 | US20030229225 Novel phosphonic acid based prodrugs of PMEA and its analogues |
| 12/11/2003 | US20030229204 PCG-1, a novel brown fat PPARgamma coactivator |
| 12/11/2003 | US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 12/11/2003 | US20030229145 Analgesics; amino acid drug |
| 12/11/2003 | US20030229130 Imidazolinylmethyl aralkylsulfonamides |
| 12/11/2003 | US20030229116 Enamine derivatives |
| 12/11/2003 | US20030229110 Cell signal transduction |
| 12/11/2003 | US20030229104 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines |
| 12/11/2003 | US20030229095 Sexual disorders |
| 12/11/2003 | US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 12/11/2003 | US20030229088 Novel methods and compositions for alleviating pain |
| 12/11/2003 | US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 12/11/2003 | US20030229080 Cardiovascular disorders; sexual disorders |
| 12/11/2003 | US20030229069 1-Sulfonyl-4-aminoalkoxy indole derivatives and uses thereof |
| 12/11/2003 | US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | US20030229054 Novel amines as pharmaceutical agents |
| 12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/11/2003 | US20030229047 Liquid formulation of decitabine and use of the same |
| 12/11/2003 | US20030229025 Antidiabetic agents, eating disorders, dietetics |
| 12/11/2003 | US20030228625 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 12/11/2003 | US20030228379 Herbs and herbal combinations useful for the treatment of microbial infections |
| 12/11/2003 | US20030228365 Pharmaceutical formulation |
| 12/11/2003 | US20030228321 Preventives for reinfection after liver transplantation |
| 12/11/2003 | US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders |
| 12/11/2003 | CA2487905A1 Use of cgmp - stimulating compounds |
| 12/11/2003 | CA2487688A1 Piperidine derivative, process for producing the same, and use |
| 12/11/2003 | CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | CA2487299A1 Treatment of hepatitis c in the asian population with subcutaneous interferon-beta |
| 12/11/2003 | CA2486933A1 Tetrahydropyran derivative |
| 12/11/2003 | CA2486794A1 Pharmaceutical composition for controlled drug delivery system |
| 12/11/2003 | CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | CA2482639A1 3-substituted quinuclidines and their use |
| 12/11/2003 | CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 12/10/2003 | EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/10/2003 | EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives |
| 12/10/2003 | EP1369419A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 12/10/2003 | EP1369414A1 Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors |
| 12/10/2003 | EP1369120A1 Treatment of flavivirus infection |
| 12/10/2003 | EP1368473A2 Neurotransmission-associated proteins |
| 12/10/2003 | EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 12/10/2003 | EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |